Cognios Beta Neutral Large Cap Fund’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$1.04M Sell
6,585
-233
-3% -$37.1K 1.36% 19
2023
Q4
$1.07M Sell
6,818
-194
-3% -$29.7K 1.39% 15
2023
Q3
$1.09M Sell
7,012
-744
-10% -$123K 1.42% 14
2023
Q2
$1.28M Sell
7,756
-1,632
-17% -$263K 1.49% 13
2023
Q1
$1.45M Buy
9,388
+301
+3% +$48.6K 1.38% 11
2022
Q4
$1.61M Buy
+9,087
New +$1.57M 1.54% 9
2018
Q2
$203K Buy
+1,678
New +$209K 0.07% 148

Other funds holding JNJ

Cognios Beta Neutral Large Cap Fund's JNJ Position: Q1 2024 in Review

Cognios Beta Neutral Large Cap Fund reduced its Johnson & Johnson (JNJ) stake by 3.4% in Q1 2024, selling an estimated $37.1K and leaving 6,585 shares worth $1.04M. The position accounts for 1.36% of the portfolio, ranked #19.

Cognios Beta Neutral Large Cap Fund first reported a position in JNJ in Q2 2018 and has held it in 7 quarters since. The position peaked at $1.61M in Q4 2022. 3,849 funds tracked by Wall St. Rank hold JNJ as of Q1 2024.

  • Cognios Beta Neutral Large Cap Fund held 6,585 shares of Johnson & Johnson worth $1.04M as of Q1 2024.
  • Cognios Beta Neutral Large Cap Fund sold 233 Johnson & Johnson shares in Q1 2024, an estimated $37.1K.
  • Johnson & Johnson made up 1.36% of Cognios Beta Neutral Large Cap Fund's portfolio in Q1 2024, its #19 holding.
  • Cognios Beta Neutral Large Cap Fund first reported a position in Johnson & Johnson in Q2 2018 and has held it in 7 quarters since.
  • Cognios Beta Neutral Large Cap Fund's Johnson & Johnson position peaked at $1.61M in Q4 2022.
  • 3,849 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2024.

Based on Cognios Beta Neutral Large Cap Fund's 13F filing for Q1 2024, filed 8 May 2024.